Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 3968

1.

Population Pharmacokinetic-Pharmacodynamic Modeling of a Novel Methylphenidate Extended-Release Orally Disintegrating Tablet in Pediatric Patients With Attention-Deficit/Hyperactivity Disorder.

Teuscher NS, Sikes CR, McMahen R, Engelking D.

J Clin Psychopharmacol. 2018 Oct;38(5):467-474. doi: 10.1097/JCP.0000000000000944.

PMID:
30119076
2.

Case report: narcolepsy type 1 in an adolescent with HIV infection-coincidence or potential trigger?

Scherrer KS, Relly C, Hackenberg A, Berger C, Paioni P.

Medicine (Baltimore). 2018 Jul;97(30):e11490. doi: 10.1097/MD.0000000000011490.

3.
4.

Lisdexamfetamine Dimesylate: A Review in Paediatric ADHD.

Frampton JE.

Drugs. 2018 Jul;78(10):1025-1036. doi: 10.1007/s40265-018-0936-0. Review.

PMID:
29923015
5.

Novel and rapid LC-MS/MS method for quantitative analysis of methylphenidate in dried blood spots.

Gandhi A, Beekman C, Parker R, Fang L, Babiskin A, Matta MK.

Bioanalysis. 2018 Jun 1;10(11):839-850. doi: 10.4155/bio-2018-0024. Epub 2018 Jun 4.

6.

Methylphenidate Induced Acute Dystonic Reaction.

Uzun ME, Korkmaz MF, Ekici A, Kaymaz N.

Indian J Pediatr. 2018 Jul;85(7):577. doi: 10.1007/s12098-018-2711-3. Epub 2018 May 23. No abstract available.

PMID:
29790008
7.

Methylphenidate for attention deficit hyperactivity disorder (ADHD) in children and adolescents - assessment of adverse events in non-randomised studies.

Storebø OJ, Pedersen N, Ramstad E, Kielsholm ML, Nielsen SS, Krogh HB, Moreira-Maia CR, Magnusson FL, Holmskov M, Gerner T, Skoog M, Rosendal S, Groth C, Gillies D, Buch Rasmussen K, Gauci D, Zwi M, Kirubakaran R, Håkonsen SJ, Aagaard L, Simonsen E, Gluud C.

Cochrane Database Syst Rev. 2018 May 9;5:CD012069. doi: 10.1002/14651858.CD012069.pub2. Review.

PMID:
29744873
8.

Pharmacological interventions for apathy in Alzheimer's disease.

Ruthirakuhan MT, Herrmann N, Abraham EH, Chan S, Lanctôt KL.

Cochrane Database Syst Rev. 2018 May 4;5:CD012197. doi: 10.1002/14651858.CD012197.pub2. Review.

PMID:
29727467
9.

Solid phase microextraction combined with thermal-desorption electrospray ionization mass spectrometry for high-throughput pharmacokinetics assays.

Wang CH, Su H, Chou JH, Huang MZ, Lin HJ, Shiea J.

Anal Chim Acta. 2018 Aug 27;1021:60-68. doi: 10.1016/j.aca.2018.03.002. Epub 2018 Mar 20.

PMID:
29681285
10.

[All you need to know about methylphenidate (and dared not ask)].

Zimmer L, Fourneret P.

Arch Pediatr. 2018 Apr;25(3):229-235. doi: 10.1016/j.arcped.2018.01.002. Epub 2018 Mar 12. French.

PMID:
29544968
11.

On the central noradrenergic mechanism underlying the social play-suppressant effect of methylphenidate in rats.

Achterberg EJM, Damsteegt R, Vanderschuren LJMJ.

Behav Brain Res. 2018 Jul 16;347:158-166. doi: 10.1016/j.bbr.2018.03.004. Epub 2018 Mar 8.

PMID:
29526788
12.

International Consensus Statement on Screening, Diagnosis and Treatment of Substance Use Disorder Patients with Comorbid Attention Deficit/Hyperactivity Disorder.

Crunelle CL, van den Brink W, Moggi F, Konstenius M, Franck J, Levin FR, van de Glind G, Demetrovics Z, Coetzee C, Luderer M, Schellekens A; ICASA consensus group, Matthys F.

Eur Addict Res. 2018;24(1):43-51. doi: 10.1159/000487767. Epub 2018 Mar 6.

13.

QTc prolongation after ADHD medication.

Snircova E, Marcincakova Husarova V, Ondrejka I, Hrtanek I, Farsky I, Nosalova G.

Neuro Endocrinol Lett. 2018 Feb;38(8):549-554.

PMID:
29504733
14.

Methylphenidate enhances neuronal differentiation and reduces proliferation concomitant to activation of Wnt signal transduction pathways.

Grünblatt E, Bartl J, Walitza S.

Transl Psychiatry. 2018 Mar 1;8(1):51. doi: 10.1038/s41398-018-0096-8.

15.

Medication changes after switching from CONCERTA® brand methylphenidate HCl to a generic long-acting formulation: A retrospective database study.

Fife D, Cepeda MS, Baseman A, Richards H, Hu P, Starr HL, Sena AG.

PLoS One. 2018 Feb 28;13(2):e0193453. doi: 10.1371/journal.pone.0193453. eCollection 2018.

16.

Methylphenidate clinically oral doses improved brain and heart glutathione redox status and evoked renal and cardiac tissue injury in rats.

Loureiro-Vieira S, Costa VM, Duarte JA, Duarte-Araújo M, Gonçalves-Monteiro S, Maria de Lourdes B, Carvalho F, Capela JP.

Biomed Pharmacother. 2018 Apr;100:551-563. doi: 10.1016/j.biopha.2018.02.017. Epub 2018 Feb 23.

PMID:
29482048
17.

Systemic administration of guanfacine improves food-motivated impulsive choice behavior primarily via direct stimulation of postsynaptic α2A-adrenergic receptors in rats.

Nishitomi K, Yano K, Kobayashi M, Jino K, Kano T, Horiguchi N, Shinohara S, Hasegawa M.

Behav Brain Res. 2018 Jun 1;345:21-29. doi: 10.1016/j.bbr.2018.02.022. Epub 2018 Feb 21.

PMID:
29476896
18.

Methylphenidate ameliorates hypoxia-induced mitochondrial damage in human neuroblastoma SH-SY5Y cells through inhibition of oxidative stress.

Zhu M, Tian Y, Zhang H, Ma X, Shang B, Zhang J, Jiao Y, Zhang Y, Hu J, Wang Y.

Life Sci. 2018 Mar 15;197:40-45. doi: 10.1016/j.lfs.2018.01.027. Epub 2018 Jan 31.

PMID:
29378209
19.

Predicting the ergogenic response to methylphenidate.

King M, Van Breda K, Stein DJ, Lutz K, Rauch HGL.

Eur J Appl Physiol. 2018 Apr;118(4):777-784. doi: 10.1007/s00421-018-3800-8. Epub 2018 Jan 25.

PMID:
29372315
20.

Methylphenidate regulation of osteoclasts in a dose- and sex-dependent manner adversely affects skeletal mechanical integrity.

Uddin SMZ, Robison LS, Fricke D, Chernoff E, Hadjiargyrou M, Thanos PK, Komatsu DE.

Sci Rep. 2018 Jan 24;8(1):1515. doi: 10.1038/s41598-018-19894-x.

Supplemental Content

Loading ...
Support Center